Literature DB >> 6712032

Doxycycline therapy for leptospirosis.

J B McClain, W R Ballou, S M Harrison, D L Steinweg.   

Abstract

To study antibiotic efficacy, 29 patients with leptospirosis were treated in a randomized, double-blinded fashion with doxycycline, 100 mg orally twice a day, or placebo. Therapy was given for 7 days in a hospital, and patients were followed for 3 weeks afterwards. Duration of illness before therapy and severity of illness were the same in both groups. Doxycycline reduced the duration of illness by 2 days and favorably affected fever, malaise, headache, and myalgias. Treatment prevented leptospiruria and had no adverse effects. Doxycycline is effective in therapy for patients with leptospirosis.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6712032     DOI: 10.7326/0003-4819-100-5-696

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  45 in total

Review 1.  Leptospirosis.

Authors:  P N Levett
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

2.  Leptospirosis, water sports, and chemoprophylaxis.

Authors:  David A Haake; Manjula Dundoo; Rumi Cader; Bernard M Kubak; Rudy A Hartskeerl; James J Sejvar; David A Ashford
Journal:  Clin Infect Dis       Date:  2002-04-04       Impact factor: 9.079

3.  Antibiotics for Travelers: What's Good and What's Not.

Authors:  Kathryn N. Suh; Jay S. Keystone
Journal:  Curr Infect Dis Rep       Date:  2004-02       Impact factor: 3.725

4.  In vitro susceptibilities of seven Leptospira species to traditional and newer antibiotics.

Authors:  Duane R Hospenthal; Clinton K Murray
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

5.  The cardiovascular manifestations of leptospirosis.

Authors:  A C Dixon
Journal:  West J Med       Date:  1991-03

6.  Efficacy of macrolides and telithromycin against leptospirosis in a hamster model.

Authors:  James E Moon; Michael W Ellis; Michael C Ellis; Matthew E Griffith; Joshua S Hawley; Robert G Rivard; Suzanne McCall; Duane R Hospenthal; Clinton K Murray
Journal:  Antimicrob Agents Chemother       Date:  2006-06       Impact factor: 5.191

7.  Antimicrobial susceptibilities of geographically diverse clinical human isolates of Leptospira.

Authors:  Roseanne A Ressner; Matthew E Griffith; Miriam L Beckius; Guillermo Pimentel; R Scott Miller; Katrin Mende; Susan L Fraser; Renee L Galloway; Duane R Hospenthal; Clinton K Murray
Journal:  Antimicrob Agents Chemother       Date:  2008-04-14       Impact factor: 5.191

8.  ["Peculiar infection" with fever, splenomegaly and acute kidney failure in a 24-year-old forestry student].

Authors:  F Strutz; A Scheel; M Koziolek; T Kochsiek; H Eiffert; G A Müller
Journal:  Internist (Berl)       Date:  2003-12       Impact factor: 0.743

9.  Bat-associated leptospirosis.

Authors:  Neelam A Vashi; Pavani Reddy; Diane B Wayne; Bradley Sabin
Journal:  J Gen Intern Med       Date:  2009-12-09       Impact factor: 5.128

10.  Determination of susceptibilities of 26 Leptospira sp. serovars to 24 antimicrobial agents by a broth microdilution technique.

Authors:  Clinton K Murray; Duane R Hospenthal
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.